Login
Make A Payment
Services
Care Empowered Pricing
Additional Service
Balance Billing Resolution
ICE
Additional Services
Phia Document Management® (PDM)
Plan Drafting Services
PACE®
Subrogation & Recovery Services
Phia Unwrapped
Additional Services
Claim Negotiation & Signoff (CNS)
No Surprises Act (NSA)
Phia International
About Us
Welcome Video
Company Overview
Our Purpose
A Message From our CEO
Giving Back
Locations
Leadership
Executive Team
Legal Team
Testimonials
Technology
Careers
Diversity & Inclusion
Media
Industry Articles
Top Five Advantages of RBP Plans
Guide to Understanding Subrogation
Moving To Self-Funded Health Plan Guide
Reference-Based Pricing Explained
Hospital Price Transparency Guide
Balance-Billing: What Patients Need To Know
Employee Rights With COVID-19 Vaccines
The No Surprises Act Explained
Mental Health Parity and Addiction Equity Act Explained
Understanding Non-Quantitative Treatment Limitations (NQTLs)
The Insulin Cap Bill Offers Hope for Americans With Diabetes
In-Network vs Out-of-Network Claims
Gag Clause Prohibition Compliance Attestation
AI in Healthcare
Understanding Prescription Medication for Weight Loss
Webinars
Newsletters
Blog
Podcasts
Press Releases
Industry Terms
Publications
Members Area
FAQs
FAQ - Subrogation & Reimbursement
FAQ - Mass Tort Subrogation & Reimbursement
Questionnaire Response
Make A Payment
Contact
X
Services
Care Empowered Pricing
Additional Service
Balance Billing Resolution
ICE
Additional Services
Phia Document Management® (PDM)
Plan Drafting Services
PACE®
Subrogation & Recovery Services
Phia Unwrapped
Additional Services
Claim Negotiation & Signoff (CNS)
No Surprises Act (NSA)
Phia International
About Us
Welcome Video
Company Overview
Our Purpose
A Message From our CEO
Giving Back
Locations
Leadership
Executive Team
Legal Team
Testimonials
Technology
Careers
Diversity & Inclusion
Media
Industry Articles
Top Five Advantages of RBP Plans
Guide to Understanding Subrogation
Moving To Self-Funded Health Plan Guide
Reference-Based Pricing Explained
Hospital Price Transparency Guide
Balance-Billing: What Patients Need To Know
Employee Rights With COVID-19 Vaccines
The No Surprises Act Explained
Mental Health Parity and Addiction Equity Act Explained
Understanding Non-Quantitative Treatment Limitations (NQTLs)
The Insulin Cap Bill Offers Hope for Americans With Diabetes
In-Network vs Out-of-Network Claims
Gag Clause Prohibition Compliance Attestation
AI in Healthcare
Understanding Prescription Medication for Weight Loss
Webinars
Newsletters
Blog
Podcasts
Press Releases
Industry Terms
Publications
Members Area
FAQs
FAQ - Subrogation & Reimbursement
FAQ - Mass Tort Subrogation & Reimbursement
Questionnaire Response
Make A Payment
Contact
+
Services
+
Care Empowered Pricing
Additional Service
Balance Billing Resolution
+
ICE
Additional Services
Phia Document Management® (PDM)
Plan Drafting Services
PACE®
Subrogation & Recovery Services
+
Phia Unwrapped
Additional Services
Claim Negotiation & Signoff (CNS)
No Surprises Act (NSA)
Phia International
+
About Us
Welcome Video
+
Company Overview
Our Purpose
A Message From our CEO
Giving Back
Locations
+
Leadership
Executive Team
Legal Team
Testimonials
Technology
Careers
Diversity & Inclusion
-
Media
+
Industry Articles
Top Five Advantages of RBP Plans
Guide to Understanding Subrogation
Moving To Self-Funded Health Plan Guide
Reference-Based Pricing Explained
Hospital Price Transparency Guide
Balance-Billing: What Patients Need To Know
Employee Rights With COVID-19 Vaccines
The No Surprises Act Explained
Mental Health Parity and Addiction Equity Act Explained
Understanding Non-Quantitative Treatment Limitations (NQTLs)
The Insulin Cap Bill Offers Hope for Americans With Diabetes
In-Network vs Out-of-Network Claims
Gag Clause Prohibition Compliance Attestation
AI in Healthcare
Understanding Prescription Medication for Weight Loss
Webinars
Newsletters
Blog
Podcasts
Press Releases
Industry Terms
Publications
+
Members Area
+
FAQs
FAQ - Subrogation & Reimbursement
FAQ - Mass Tort Subrogation & Reimbursement
Questionnaire Response
Make A Payment
Contact
Industry Articles
Top Five Advantages of RBP Plans
Guide to Understanding Subrogation
Moving To Self-Funded Health Plan Guide
Reference-Based Pricing Explained
Hospital Price Transparency Guide
Balance-Billing: What Patients Need To Know
Employee Rights With COVID-19 Vaccines
The No Surprises Act Explained
Mental Health Parity and Addiction Equity Act Explained
Understanding Non-Quantitative Treatment Limitations (NQTLs)
The Insulin Cap Bill Offers Hope for Americans With Diabetes
In-Network vs Out-of-Network Claims
Gag Clause Prohibition Compliance Attestation
AI in Healthcare
Understanding Prescription Medication for Weight Loss
Webinars
Newsletters
Blog
Podcasts
Press Releases
Industry Terms
Publications
Phia Group
Phia Group Media
Navigating Mental Health Parity: What Self-Funded Plans Need to Know
On April 24, 2025
In 2008, under the George W. Bush administration, the Mental Health Parity and Addiction Equity Act (MHPAEA) was enacted to ensure that health insurance plans did not impose more restrictive limitations on mental health and substance use disorder (MH/SUD) benefits – assuming they were initially covered – than those imposed on medical and surgical (M/S) benefits. More specifically, health insurers were forbidden from applying limitations such as prior authorizations, unreasonably high copays, or visit restrictions to mental health/substance use disorder treatments when medical/surgical treatments did not have such imposing constraints.
A Discussion of the Executive Order to Lower Drug Prices
On April 23, 2025
The high costs associated with prescription drugs consistently provoke conversation in the self-funded healthcare industry. Not only is it an issue that most health plans encounter, but it is also a concern that trickles down to the member-level. Whether you’ve personally experienced the effects of high-cost drugs, or they have impacted a close family member, we can all empathize with the stress of having to pay for an expensive prescription.
AI to the Rescue? How Machine Learning May Revolutionize Drug Repurposing
On April 15, 2025
Without question, artificial intelligence beholds many downright frightening risks when implemented in the healthcare field. Without proper oversight, AI could have the final say in depriving a patient of a necessary procedure or steering them towards a suboptimal physician. Or the still nascent technology, if unchecked, could account for a HIPAA breach with the slapdash handling of PHI. Yet, that being said, AI is undoubtedly here to stay and as far as the healthcare industry is concerned, this technological revolution is brimming with astonishing potential, as evidenced by the recent development of AI expediting the repurposing of existing drugs for treatment of rare diseases.
Tariff Talk - How Trump’s Pharmaceutical Tariffs Could Impact You (and How You Can Prepare)
On April 11, 2025
As the self-insurance industry braces for potential changes under President Trump’s administration, one issue looms large: impending tariffs on pharmaceutical drugs. These proposed tariffs, aimed at boosting domestic manufacturing, could ripple through the healthcare ecosystem, affecting employers sponsoring self-funded health plans, third-party administrators (TPAs), stop-loss carriers, brokers, and vendors. For an industry built on balancing cost control with quality care, understanding these impacts and preparing strategically is critical. More importantly, as we navigate these changes, we must remain steadfast in our commitment to ensuring that our members get access to quality, affordable prescription drugs.
Care Empowered Pricing as a Money Saver
On April 10, 2025
For over a quarter century, The Phia Group has championed a broad spectrum of cost containment initiatives to empower health plans and ultimately, their respective participants. The Phia Group believes that its latest endeavor—Care Empowered Pricing (CEP)—may be its most robust cost containment program yet. At its core, CEP is engineered to, quite simply, save plans money and as you can see below, there are a number of ways our revolutionary offering does so.
Overhauling HHS – Can a Leaner, Meaner HHS Make America Healthy Again?
On April 7, 2025
The second Trump administration has not been shy about taking steps to shake up U.S. health policy. There has been a flurry of executive orders on a range of healthcare topics, including stepping up enforcement of price transparency rules; a push to expand coverage for and lower the out-of-pocket costs for in vitro fertilization; and taking steps to redefine sex-based discrimination in federal policy and to discourage treatments for gender dysphoria. Even so, the executive action poised to have the broadest impact on health policy may just be the sweeping changes being made to the Department of Health and Human Services (HHS).
The Social Impact of Mental Health Parity Testing Explained
On March 24, 2025
Explore the social impact of mental health parity testing, including its effects on access to care, stigma reduction, and the importance of equitable treatment.
Pancreatic Cancer Vaccine | A New Hope on the Horizon
On March 17, 2025
Learn about the promising new pancreatic cancer vaccine, Lenmeldy, & its potential to revolutionize treatment for this disease & improve patient outcomes.
Struggling to Breathe | The Global Medical Oxygen Crisis
On February 26, 2025
Explore the global crisis of medical oxygen access, highlighting disparities in availability in low-income countries & its impact on patient care.
Journavx | A New Non-Opioid Solution for Pain Management
On February 11, 2025
Learn about Journavx, a groundbreaking non-opioid analgesic designed to treat acute pain, & its implications for patients seeking safer pain management options.
House Republicans Propose Changes to HSA-Qualified HDHPs
On January 24, 2025
Learn about the implications of H.R. 5688, which aims to enable individuals to contribute to HSAs while using direct primary care, benefiting those with HDHPs.
The Invisible Truth of Healthcare | Cost vs. Quality
On January 24, 2025
Explore the hidden truths of healthcare costs and quality, highlighting the disparities in pricing and the need for patients to become informed consumers.
The Phia Group's Role in Transforming Healthcare with AI
On January 13, 2025
Learn about the merger of The Phia Group & Machinify, focusing on innovative AI technology that streamlines the healthcare claims lifecycle & improves outcomes.
An App for What Ails You
On January 13, 2025
This is the future presaged by “PDURS” (Prescription Drug Use-Related Software). One of the sillier acronyms to grace the healthcare industry in recent memory, PDURS are defined by the FSDA as “software disseminated by or on behalf of a drug sponsor that accompanies one or more of the sponsor’s prescription drugs, including biological drug products.” Essentially, most patients will encounter this software as an app, paired with marquee prescription drugs, that is designed to “assist” patients and healthcare providers in the prescription and use of the medication.
Wesco v. BCBSM | Understanding Implications for Healthcare
On January 8, 2025
Explore the implications of the Wesco v. BCBSM lawsuit, focusing on the impact of cross-plan offsetting on healthcare costs and the rights of self-funded plans.
1
2
3
4
Next
film izle